Immunic, inc. announces appointment of inderpal singh as general counsel

New york, june 1, 2021 /prnewswire/ -- immunic, inc. (nasdaq: imux), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, announced the appointment of inderpal singh as general counsel, effective today. in his new role, mr.

IMUX Ratings Summary

IMUX Quant Ranking